[Isoniazid-induced acute pancreatitis].
Briongos-Figuero
Laisa Socorro
LS
Bachiller-Luque
Pablo
P
Pons-Renedo
Fernando
F
Eiros-Bouza
José María
JM
D000208:Acute Disease; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005265:Femoral Neck Fractures / Q000188:drug therapy / Q000209:etiology; D005598:Fractures, Spontaneous / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects* / Q000627:therapeutic use; D010195:Pancreatitis / Q000139:chemically induced*; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy / Q000209:etiology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin